QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.17B
Market cap8.17B
Price-Earnings ratio
19.54
Price-Earnings ratio19.54
Dividend yield
0.66%
Dividend yield0.66%
Average volume
2.36M
Average volume2.36M
High today
$40.47
High today$40.47
Low today
$39.02
Low today$39.02
Open price
$39.99
Open price$39.99
Volume
1.86M
Volume1.86M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$38.13
52 Week low$38.13

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $39.49. The company's market cap stands at 8.17B, with a P/E ratio of 19.54 and a dividend yield of 65.9%.

On 2026-03-23, QIAGEN(QGEN) stock moved within a range of $39.02 to $40.47. With shares now at $39.49, the stock is trading +1.2% above its intraday low and -2.4% below the session's peak.

Trading volume for QIAGEN(QGEN) stock has reached 1.86M, versus its average volume of 2.36M.

Over the past 52 weeks, QIAGEN(QGEN) stock has traded between a high of $57.82 and a low of $38.13.

Over the past 52 weeks, QIAGEN(QGEN) stock has traded between a high of $57.82 and a low of $38.13.

QGEN News

Simply Wall St 4d
Qiagen’s TB And GI Testing Moves Draw Investor Valuation Interest

Qiagen (NYSE:QGEN) reported new clinical data supporting its QuantiFERON-TB Gold Plus test for tuberculosis infection, with a focus on immunocompromised and oth...

Qiagen’s TB And GI Testing Moves Draw Investor Valuation Interest
TipRanks 4d
Qiagen announces newly published data supporting efficacy of QuantiFERON

QIAGEN (QGEN) N.V. “announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus blood test for detecting tube...

Analyst ratings

63%

of 24 ratings
Buy
37.5%
Hold
62.5%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.